La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Mesh.i » - entrée « Receptors, Dopamine D2 »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Receptors, Dopamine D1 < Receptors, Dopamine D2 < Receptors, Dopamine D3  Facettes :

List of bibliographic references indexed by Receptors, Dopamine D2

Number of relevant bibliographic references: 42.
[0-20] [0 - 20][0 - 42][20-40]
Ident.Authors (with country if any)Title
000398 (2016) Doris E. Payer ; Mark Guttman ; Stephen J. Kish ; Junchao Tong ; John R. Adams ; Pablo Rusjan ; Sylvain Houle ; Yoshiaki Furukawa ; Alan A. Wilson ; Isabelle BoileauD3 dopamine receptor-preferring [11C]PHNO PET imaging in Parkinson patients with dyskinesia
000429 (2016) Serdar Durdagi [Turquie] ; Ramin Ekhteiari Salmas [Turquie] ; Matthias Stein [Allemagne] ; Mine Yurtsever [Turquie] ; Philip SeemanBinding Interactions of Dopamine and Apomorphine in D2High and D2Low States of Human Dopamine D2 Receptor Using Computational and Experimental Techniques.
000470 (2015) Doris E. Payer [Canada] ; Mark Guttman ; Stephen J. Kish ; Junchao Tong ; Antonio Strafella ; Martin Zack ; John R. Adams ; Pablo Rusjan ; Sylvain Houle ; Yoshiaki Furukawa ; Alan A. Wilson ; Isabelle Boileau[¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disorders.
000665 (2015) Dayne A. Beccano-Kelly ; Mattia Volta ; Lise N. Munsie ; Sarah A. Paschall ; Igor Tatarnikov ; Kimberley Co ; Patrick Chou ; Li-Ping Cao ; Sabrina Bergeron ; Emma Mitchell ; Heather Han ; Heather L. Melrose [États-Unis] ; Lucia Tapia ; Lynn A. Raymond [Canada] ; Matthew J. Farrer ; Austen J. Milnerwood [Canada]LRRK2 overexpression alters glutamatergic presynaptic plasticity, striatal dopamine tone, postsynaptic signal transduction, motor activity and memory.
000789 (2015) Christina Poetschke [Allemagne] ; Elena Dragicevic [Allemagne] ; Johanna Duda [Allemagne] ; Julia Benkert [Allemagne] ; Antonios Dougalis [Allemagne] ; Roberta Dezio [Allemagne] ; Terrance P. Snutch [Canada] ; Joerg Striessnig [Autriche] ; Birgit Liss [Allemagne]Compensatory T-type Ca2+ channel activity alters D2-autoreceptor responses of Substantia nigra dopamine neurons from Cav1.3 L-type Ca2+ channel KO mice
000936 (2014) Leigh Christopher [Canada] ; Sarah Duff-Canning [Canada] ; Yuko Koshimori [Canada] ; Barbara Segura [Canada, Espagne] ; Isabelle Boileau [Canada] ; Robert Chen [Canada] ; Anthony E. Lang [Canada] ; Sylvain Houle [Canada] ; Pablo Rusjan [Canada] ; Antonio P. Strafella [Canada]Salience Network and Parahippocampal Dopamine Dysfunction in Memory-Impaired Parkinson Disease
000B24 (2014) Philip Seeman [Canada]Clozapine, a fast-off-D2 antipsychotic.
000B35 (2014) Matthew D. Walker [Canada] ; Mattia Volta [Canada] ; Stefano Cataldi [Canada] ; Katherine Dinelle [Canada] ; Dayne Beccano-Kelly [Canada] ; Lise Munsie [Canada] ; Rick Kornelsen [Canada] ; Chenoa Mah [Canada] ; Patrick Chou [Canada] ; Kimberley Co [Canada] ; Jaskaran Khinda [Canada] ; Marta Mroczek [Canada] ; Sabrina Bergeron [Canada] ; Katrina Yu [Canada] ; Li Ping Cao [Canada] ; Natalja Funk [Allemagne] ; Thomas Ott [Allemagne] ; Dagmar Galter [Suède] ; Olaf Riess [Allemagne] ; Saskia Biskup [Allemagne] ; Austen J. Milnerwood [Canada] ; A Jon Stoessl [Canada] ; Matthew J. Farrer [Canada] ; Vesna Sossi [Canada]Behavioral deficits and striatal DA signaling in LRRK2 p.G2019S transgenic rats: a multimodal investigation including PET neuroimaging.
000E23 (2013) Leigh Christopher [Canada] ; Connie Marras [Canada] ; Sarah Duff-Canning [Canada] ; Yuko Koshimori [Canada] ; Robert Chen [Canada] ; Isabelle Boileau [Canada] ; Barbara Segura [Canada, Espagne] ; Oury Monchi [Canada] ; Anthony E. Lang [Canada] ; Pablo Rusjan [Canada] ; Sylvain Houle [Canada] ; Antonio P. Strafella [Canada]Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson’s disease with mild cognitive impairment
002305 (2008) Philip Seeman [Canada] ; Carla Caruso [Argentine] ; Mercedes Lasaga [Argentine]Memantine agonist action at dopamine D2High receptors
002903 (2006) Pepijn Van Den Munckhof [Canada] ; Francois Gilbert [Canada] ; Michel Chamberland [Canada] ; Daniel Levesque [Canada] ; Jacques Drouin [Canada]Striatal neuroadaptation and rescue of locomotor deficit by L-dopa in aphakia mice, a model of parkinson's disease
002999 (2005) Philip Seeman [Canada] ; Françoise Ko ; Matth Us Willeit ; Patrick Mccormick ; Nathalie GinovartAntiparkinson concentrations of pramipexole and PHNO occupy dopamine D2(high) and D3(high) receptors.
002A37 (2005) John R. Adams ; Hinke Van Netten ; Michael Schulzer ; Edwin Mak ; Jessamyn Mckenzie ; Audrey Strongosky [États-Unis] ; Vesna Sossi ; Thomas J. Ruth ; Chong S. Lee ; Matthew Farrer [États-Unis] ; Thomas Gasser [Allemagne] ; Ryan J. Uitti [États-Unis] ; Donald B. Calne ; Zbigniew K. Wszolek [États-Unis] ; A. Jon StoesslPET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation
002D61 (2003) Doris J. Doudet [Canada] ; James E. HoldenRaclopride studies of dopamine release: dependence on presynaptic integrity.
002F15 (2003) Pershia Samadi [Canada] ; Laurent Gregoire [Canada] ; Paul J. Bedard [Canada]Opioid antagonists increase the dyskinetic response to dopaminergic agents in parkinsonian monkeys: interaction between dopamine and opioid systems
002F82 (2002) Philip Seeman [Canada]Atypical antipsychotics: mechanism of action.
003032 (2002) Yun J. Kim [Canada] ; Masanori Ichise [Canada] ; James R. Ballinger [Canada] ; Douglas Vines [Canada] ; Sean S. Erami [Canada] ; Tatsuro Tatschida [Canada] ; Anthony E. Lang [Canada]Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP
003562 (2000) M. Goulet [Canada] ; R. Grondin [Canada] ; M. Morissette [Canada] ; S. Maltais [Canada] ; P. Falardeau [Canada] ; P. J. Bedard [Canada] ; T. Di Paolo [Canada]Regulation by chronic treatment with cabergoline of dopamine D1 and D2 receptor levels and their expression in the striatum of Parkinsonian-Monkeys
003861 (1998) P. Seeman [Canada] ; R. Corbett ; H H Van TolDopamine D4 receptors may alleviate antipsychotic-induced parkinsonism.
003867 (1998) M. Morissette ; M. Goulet ; R. Grondin ; P. Blanchet ; P J Bédard ; T. Di Paolo ; D. LévesqueAssociative and limbic regions of monkey striatum express high levels of dopamine D3 receptors: effects of MPTP and dopamine agonist replacement therapies.
003868 (1998) P. Seeman [Canada] ; T. TallericoAntipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Receptors, Dopamine D2" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Receptors, Dopamine D2" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Receptors, Dopamine D2
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022